|
TRIM24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.767500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.897300E-03 |
| Normal-vs-Stage2 |
4.700400E-03 |
| Normal-vs-Stage3 |
9.859400E-01 |
| Normal-vs-Stage4 |
6.563200E-01 |
| Stage1-vs-Stage2 |
2.075800E-01 |
| Stage1-vs-Stage3 |
2.685700E-02 |
| Stage1-vs-Stage4 |
1.246440E-01 |
| Stage2-vs-Stage3 |
8.976400E-03 |
| Stage2-vs-Stage4 |
2.624500E-02 |
| Stage3-vs-Stage4 |
6.759400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.184400E-01 |
| Normal-vs-AfricanAmerican |
1.654370E-01 |
| Normal-vs-Asian |
2.114800E-01 |
| Caucasian-vs-AfricanAmerican |
3.136200E-01 |
| Caucasian-vs-Asian |
6.903600E-01 |
| AfricanAmerican-vs-Asian |
5.178200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.338480E-02 |
| Normal-vs-Female |
9.007900E-02 |
| Male-vs-Female |
1.605790E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.246140E-02 |
| Normal-vs-Age(41-60Yrs) |
4.380800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.241900E-02 |
| Normal-vs-Age(81-100Yrs) |
9.202200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.763500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.402600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.600600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.275610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.518400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.424800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.396500E-04 |
| Classical-VS-Follicular |
7.841900E-03 |
| Classical-VS-Other |
4.072000E-01 |
| Classical-VS-Normal |
5.035700E-02 |
| Tall-VS-Follicular |
1.17899999996229E-06 |
| Tall-VS-Other |
4.813200E-01 |
| Tall-VS-Normal |
5.459600E-02 |
| Follicular-VS-Other |
1.619890E-02 |
| Follicular-VS-Normal |
2.394900E-04 |
| Other-VS-Normal |
6.843800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.742240E-02 |
| Normal-vs-N1 |
9.977000E-01 |
| N0-vs-N1 |
4.873600E-02 |
|
|
